FDA Gives Final Approval to Sodium Oxybate for Cataplexy or Excessive Daytime Sleepiness in Adults With Narcolepsy

The final approval was based on efficacy and safety data from the phase 3 REST-ON study.

Related Keywords

United States ,Greg Divis ,Michaelj Thorpy ,Avadel Pharmaceuticals ,Wake Disorders Center At Montefiore Medical ,Albert Einstein College Of Medicine ,Orphan Drug ,Sleep Wake Disorders Center ,Montefiore Medical Center ,Albert Einstein College ,